During the past decade, OptumCare Cancer Care at Charleston conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 6 clinical trials were completed, i.e. on average, 6.2% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 6 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OptumCare Cancer Care at Charleston" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OptumCare Cancer Care at Charleston" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Brain Science Foundation" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "OptumCare Cancer Care at Charleston" are "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Prognostic Stage II Breast Cancer AJCC v8" (4 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "OptumCare Cancer Care at Charleston" in a lesser frequency.

Most popular intervention types in "OptumCare Cancer Care at Charleston" are "Drug" (79 trials), "Other" (60 trials), "Biological" (52 trials), "Procedure" (47 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (34 trials), "Computed Tomography" (32 trials), "Biospecimen Collection" (30 trials), "Questionnaire Administration" (27 trials) and "Nivolumab" (23 trials). Other intervention names were less common.

The vast majority of trials in "OptumCare Cancer Care at Charleston" are 95 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "OptumCare Cancer Care at Charleston". undefined are not yet recruiting, 51 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in OptumCare Cancer Care at Charleston, 7 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in OptumCare Cancer Care at Charleston, 3 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".